Azemar, M <br/><br/>
Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo.  [electronic resource] 

 -  International journal of cancer  Apr 2000 
 - 269-75 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0215(20000415)86:2<269::aid-ijc18>3.0.co;2-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP Ribose Transferases<br/>Animals<br/>Antibodies, Monoclonal<br/>Bacterial Toxins<br/>Carcinoma, Squamous Cell--chemistry<br/>Cell Division<br/>ErbB Receptors--analysis<br/>Exotoxins--administration & dosage<br/>Head and Neck Neoplasms--chemistry<br/>Humans<br/>Immunotoxins--immunology<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Receptor, ErbB-2--analysis<br/>Recombinant Fusion Proteins--immunology<br/>Tumor Cells, Cultured<br/>Virulence Factors<br/>Pseudomonas aeruginosa Exotoxin A